Siegfried Achieves Desired Scale After Completing Novartis Plant Deal

Two Sites In Spain Will ‘Significantly Enhance’ Capacity

Siegfried has completed the acquisition of two Spanish manufacturing facilities from Novartis, in a move that will significantly enhance the Swiss CDMO’s capacity.

Barcelona
The two sites are located in the Barcelona region • Source: Shutterstock

Siegfried has announced the completion of its deal to acquire two Spanish manufacturing facilities from Novartis. The addition of the two plants, located in the Barcelona region in Barberà del Vallès and El Masnou, means that the Swiss contract development and manufacturing organization has now achieved “the targeted critical size,” Siegfried said.

While the site in El Masnou will expand Siegfried’s capacity for ophthalmology products and sterile filling, complementing the capabilities offered...

More from Deals

More from Business